| http://www.w3.org/ns/prov#value | - Second, the ???big push into emerging markets??? should empower GSK and other pharmaceutical companies to work within the not-for-profit Global Alliance for Vaccines and Immunisation (GAVI) in which rich countries and foundations provide the funds to spur the pharmaceutical companies to focus on developing vaccines for diseases for the poor.
|
